Paper17123761
Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats.
Nakagawa T and 5 others. J Ethnopharmacol, 2007. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats. Papers, record 17123761. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17123761
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protective effects of keishibukuryogan on the kidney of spontaneously diabetic WBN/Kob rats.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Experimental | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Kidney | Major topic |
| Oxidative Stress | Major topic |
| 8-Hydroxy-2'-Deoxyguanosine | |
| Animals | |
| Blood Glucose | |
| Creatinine | |
| Deoxyguanosine | |
| Fibronectins | |
| Hyperglycemia | |
| Lipid Peroxidation | |
| Male | |
| Medicine, Traditional | |
| Organ Size | |
| Phytotherapy | |
| Plant Preparations | |
| Protective Agents | |
| Proteinuria | |
| Rats | |
| Rats, Wistar | |
| Transforming Growth Factor beta1 | |
| Weight Loss |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35529925 | The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35529925 | PubMed |
| 35004802 | A Review on the Mechanism and Application of Keishibukuryogan. | Front Nutr | 2021 | https://conductscience.org/library/papers/35004802 | PubMed |
| 30235697 | Traditional Chinese medicine decreases the obstructive uropathy risk in uterovaginal prolapse: A nationwide population-based study. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30235697 | PubMed |
| 28018473 | Evaluation of the In Vivo Therapeutic Effects of Radix Paeoniae Rubra Ethanol Extract with the Hypoglycemic Activities Measured from Multiple Cell-Based Assays. | Evid Based Complement Alternat Med | 2016 | https://conductscience.org/library/papers/28018473 | PubMed |
| 27549514 | Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase. | Sci Rep | 2016 | https://conductscience.org/library/papers/27549514 | PubMed |
| 27342654 | Clinical study of total glucosides of paeony for the treatment of diabetic kidney disease in patients with diabetes mellitus. | Int Urol Nephrol | 2016 | https://conductscience.org/library/papers/27342654 | PubMed |
| 25793003 | Effect of keishibukuryogan on genetic and dietary obesity models. | Evid Based Complement Alternat Med | 2015 | https://conductscience.org/library/papers/25793003 | PubMed |
| 23529746 | Chinese medicine for treating diabetic nephropathy. | Chin J Integr Med | 2011 | https://conductscience.org/library/papers/23529746 | PubMed |
| 23044503 | The effects of medicinal plants on renal function and blood pressure in diabetes mellitus. | Cardiovasc J Afr | 2012 | https://conductscience.org/library/papers/23044503 | PubMed |
| 21253500 | The traditional Japanese formula keishibukuryogan inhibits the production of inflammatory cytokines by dermal endothelial cells. | Mediators Inflamm | 2010 | https://conductscience.org/library/papers/21253500 | PubMed |
| 19633031 | Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model. | Evid Based Complement Alternat Med | 2011 | https://conductscience.org/library/papers/19633031 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17123761
GET https://conductscience.org/api/papers/v1/17123761/authors